Titan Medical Inc (TMDI) Quote

Agree with you. Worst financial mistake of a lifetime. I regret hearing about this company and will never invest in a penny again.

Checking in probably one last time here as I've lost over 150k on this.. worst experience of my life.. even more painful that it went on for 12 plus years of pain. I'm writing here one last time hoping that no one is voting yes on this.. and if you do you might as well vote for Kamala as well. After losing 150k + and still having all those shares that have been reverse split who knows how many times I'm left with a total of just 1,500 or so in stock.. a yes vote will bring even less. Only one getting paid will be the company directors on both side and lawyers.. please vote no and shut these scammers down! And I won't be attending the conference call because there's nothing to hear. It's been fun communicating with some of you over the years here. Big lesson learned here. And that this place is full of evil people trying to scam all day everyday

what a steal!
https://titanmedicalinc.com/enos/
https://titanmedicalinc.com/videos/
https://titanmedicalinc.com/technology/
https://titanmedicalinc.com/wp-content/uploads/2022/10/Titan-Medical-White-Paper-Supporting-Single-Access-RAS-FINAL.pdf 🤮
simply thieves!

Can you please explain why you are recommending a no vote? I don’t think this company as it stands will be able to continue if they don’t do something. but in all honesty I haven’t read the circular yet so I don’t really have an educated opinion as of today. But I appreciate any info you are willing to provide. Thanks in advance and good luck. We may need it. Lol.

Withhold!!!

VOTE NO!!!!

https://ir.titanmedicalinc.com/news-events/press-releases/detail/414/titan-announces-filing-of-the-management-information

What’s going on with the voting ?

https://www.medicaldevice-network.com/data-insights/titan-medical-gets-grant-for-method-for-ergonomic-positioning-of-robotic-surgery-input-device/

No R&D……where did all those MILLIONS go since 12/31/23?????

VOTE NO!!!!!!!!

Titan Medical Reports Operating and Financial Results for the Second Quarter 2024
Titan Medical Inc.
Thu, Aug 15, 2024, 11:32 AM CDT6 min read\

TORONTO, Ontario, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), today reported financial results for the three and six months ended June 30, 2024.

Recent Activities in Q2 2024:

On May 29, 2024, the Company announced an amendment to the timeframe under which certain closing conditions must be met in the amalgamation agreement dated March 17, 2024 with Conavi Medical Inc. (“Conavi”), 1000824255 Ontario Inc. (a wholly-owned subsidiary of Titan) (the “Amalgamation Agreement”).

On July 5, 2024, the Company announced the second amendment to the timeframe under which certain conditions must be met in the Amalgamation Agreement and announced the Company was seeking an additional extension with the Toronto Stock Exchange (“TSX”) to hold its Annual General and Special Meeting of Shareholders (the “Titan AGM”) on or before September 30, 2024.

On August 14, 2024, the Company announced the third amendment to alter certain closing conditions that must be met in the Amalgamation Agreement.

extending the Outside Date (as such term is defined in the Amalgamation Agreement) for completion of the Proposed Transaction to October 10, 2024;

extending the date by which the Concurrent Financing (as such term is defined in the Amalgamation Agreement) must be committed to September 3, 2024;

reducing the minimum aggregate size of the Concurrent Financing (as such term is defined in the Amalgamation Agreement) from $15 million to $7.5 million;

extending the date by which Conavi financial statements must be completed to August 23, 2024;

reducing the minimum net cash Titan must have at the Effective Time (as such term is defined in this Amalgamation Agreement) from US$5 million to US$2 million;

extending the targeted date by which the information circular for the Titan AGM must be mailed to shareholders to September 3, 2024;

extending the targeted date by which the Titan AGM must be held to September 30, 2024;

extending the targeted date by which the information circular for the Conavi annual general meeting must be mailed to shareholders to September 3, 2024; and

extending the targeted date by which the Conavi annual general meeting must be held to September 30, 2024.

Financial Highlights:

As of June 30, 2024, Titan had cash of $3.9 million, compared to $7.5 million as at December 31, 2023. Working capital was $3.3 million as of June 30, 2024, compared to $5.5 million as at December 31, 2023.

Research and development (“R&D”) expenses were nil for the three months ended June 30, 2024 compared to $0.4 million for the three months ended June 30, 2023. R&D expenses were recovery of $0.1 million for the six months ended June 30, 2024 compared to $0.8 million for the six months ended June 30, 2023.

In the three and six months ended June 30, 2023, the Company implemented cost-cutting measures that significantly reduced R&D expenses. In the six months ended June 30, 2024, R&D expense recovery of $0.1 million is attributed to cancellation of stock options and restricted share units related to R&D personnel.

General and administrative (“G&A”) expenses were $1.1 million and $2.0 million for the three and six months ended June 30, 2024 compared to $4.3 million and $6.6 million for the comparative periods ended June 30, 2023. The decrease in G&A expenses in the current period is related to the cost-cutting measures implemented in Q2, 2023. In 2023, G&A expenses included severance charges of $1.4M, transaction costs of $1.5M, and increased stock-based compensation, offset by reduction in costs due to cost-cutting measures.

The Company’s interim consolidated financial statements and management discussions and analysis for the period ended June 30, 2024 are available at www.sedarplus.ca. The Company’s condensed interim consolidated financial statements have been prepared by management and reviewed by the Company’s auditors.

About Titan Medical

Titan Medical Inc. (TSX: TMD; OTC: TMDIF) is a medical technology company incorporated under the Business Corporations Act (Ontario) and headquartered in Toronto, Ontario, has developed an expansive patent portfolio related to the enhancement of robotic assisted surgery (RAS), including through a single access point, and is currently focused on evaluating new opportunities to further develop and license its intellectual property while pursuing the completion of its agreed upon Transaction with Conavi Medical Inc.

Cautionary Statement Regarding Forward-Looking Information

This news release contains “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws, which reflect the current expectations of management of Titan’s future growth, results of operations, performance and business prospects and opportunities. Forward-looking statements are frequently, but not always, identified by words such as “may”, “would”, “could”, “will”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”, “potential for” and similar expressions, although these words may not be present in all forward-looking statements. Forward-looking statements that appear in this release may include, without limitation, references to: Titan evaluating new opportunities to further develop and license its intellectual property, the payment of future settlement amounts, the delivery of materials to Titan, and the completion of the merger with Conavi.

These forward-looking statements reflect management’s current beliefs with respect to future events, and are based on information currently available to management that, while considered reasonable by management as of the date on which the statements are made, are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in actions, events, conditions, results, performance or achievements to be materially different from those projected in the forward-looking statements. Forward-looking statements involve significant risks, uncertainties and assumptions and many factors could cause Titan’s actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements. Such factors and assumptions include, but are not limited to, Titan’s ability to retain key personnel; its ability to execute on its business plans and strategies; its ability to continue to license some or all its intellectual property to third parties and receive any material consideration and other factors listed in the “Risk Factors” section of Titan’s Annual Information Form for the fiscal year ended December 31, 2023 (which may be viewed at www.sedarplus.com). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance, or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements.

Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions and Titan has attempted to identify important factors that could cause actual actions, events, conditions, results, performance or achievements to differ materially from those described in forward-looking statements, Titan cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. Except as required by law, Titan expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. Accordingly, investors should not place undue reliance on forward-looking statements. All the forward-looking statements are expressly qualified by the foregoing cautionary statements.

Contact
Chien Huang
Chief Financial Officer
investors@titanmedicalinc.com

Vote NO to reverse takeover.

Why vote yes and lock in our 99.9% loss?

Upside? What upside? You realize they’ve robbed stakeholders right? They’ve spent hundreds of millions on a single-port robot and they stopped development. They pissed away their entire IP portfolio for pennies and no one even knows where the device is at this point.

Happy Sunday. I'm a weekend warrior that recently discovered the Investors hub community. Been following the developments with Titan Medical Inc. (TMD) licensing deals with others for near future royalties, and also the pending Conavi Medical reverse buyout / merger. As per the info I have read in the Links below, I gather that they are in talks to Delist from the TSX: TMD; OTC: TMDIF),to then move to the TSXV after the deal hopefully gets done. I believe there is good upside with the TMD company either way. Therefore, can anyone that is savvy with this type of company reverse buyout/merger restructuring terms etc., please advise if TMD will want to, or will have to Change their Trading Symbol for the transition to the TSXV ? Thanks, appreciate any thoughts and/or comments for insight on what we may potentially be able to anticipate.

https://ih.advfn.com/stock-market/USOTC/vivos-qb-RDGL/stock-news/94191743/form-1-a-a-offering-statement-regulation-a-a
https://acrobat.adobe.com/id/urn:aaid:sc:VA6C2:d031aa10-2849-4915-827d-efa78f75b532
https://acrobat.adobe.com/id/urn:aaid:sc:VA6C2:a181e427-d506-468b-8fbf-093ff89ad5a6

APPLICATION NO 18/561705
DATE FILED 2022-05-26


what a steal!

CATAcock!!!!!

what a steal!

https://www.linkedin.com/posts/nickisuttoncdp_titan-medical-enos-next-generation-technology-activity-7205992450815836160-cPhl?utm_source=share&utm_medium=member_ios

Link?

CDP is promoting ENOS on LinkedIn. WTF???????

NEWS OUT!!!

Doesn’t look good for the merger IMO

I see the naysayers are out today…..

The ship sank. We are ghosts in a graveyard.

Sad. This was such a thriving message board at one time. Last one out please hit the lights.

Sorry wrong board…

Is the CEO still residing in the United States or has he left the country?

God bless and good luck people

Nice close

Awful

Have not dropped a cent in this slot for many years because just like any slot machine after you put your money in you pull the handle and say goodbye . The wilds were so called MDT deals that kept players pulling the handle but eventually it dries up and so goes the player .

we go from the 1st mdt deal and 3.60 and being close to starting fda process.now 4 yrs later 5 cents,awful.good luck with with the lawsuit if there is 1,God bless all and good luck 2

Titan disputes they owe contracted manufacturer anything…

Two months later… Titan settles dispute with contracted manufacturer for $2 million LOL

Guess they were wrong. How long Titan batting ZERO against the world!!

BelizeMe

BOOM!

TORONTO, Ontario, March 04, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), announced today that the Company plans to issue its year-end 2023 financial results after the market closing on March 29, 2024.
sedar is under maintenance!
Let's wait for the market to close! 🤦

No more “BOOM!” More like a “pop” followed by a deflating tire sound.

why do we have to pay for these patents?
Will the inventors make money?
Well, a patent like this is now going to piss you off!

SYSTEM AND APPARATUS FOR INSERTION OF AN INSTRUMENT INTO A BODY CAVITY FOR PERFORMING A SURGICAL PROCEDURE
DOCUMENT ID
US 20240099794 A1
DATE PUBLISHED
2024-03-28
INVENTOR INFORMATION
NAME
CITY
STATE
ZIP CODE
COUNTRY
Genova; Perry A.
Chapel Hill
NC
N/A
US
McNally; David
Salt Lake City
UT
N/A
US
APPLICANT INFORMATION
NAME
Titan Medical Inc.
CITY
Toronto
STATE
N/A
ZIP CODE
N/A
COUNTRY
CA
AUTHORITY
N/A
TYPE
assignee
APPLICATION NO
18/481912
DATE FILED
2023-10-05
DOMESTIC PRIORITY (CONTINUITY DATA)
parent US continuation 17227617 20210412 parent-grant-document US 11779418 child US 18481912

parent US continuation 16273442 20190212 parent-grant-document US 11000339 child US 17227617

parent US continuation 16053232 20180802 p

Another thing I learned on the conference call is that.. wait for it.. it's NOT all in the patents. In fact there was nothing in the patents

Thanks for the report!

Exciting Times!

Did anybody else listen to that ridiculous conference call today? I did just for a good last laugh and cry.. I was actually surprised by a couple of the preset questions that they took.. like what happens to my shares, what happens if I don't vote for the merger and Maybe two more similar questions.. of course they said you'll be worse off if you don't vote for it.. I know it would be a shame since I'm 99.9% down to think I might lose a 10th of a percent.. fuck these assholes and everything they said leading up to the Q&A part.. not not even a question.. I'll be screaming no vote.. a yes vote will only put money to the people that worked this magical merger including the lawyers and Raymond James.. I'll be glad when it's finally over and I never have to come to this message board again and think about the 150k Plus lost here

March 29 is Good FRIDAY .
WTF?
EARNINGS ?

.04

Revenge is the only thing you can get out of this! Let's sue the F out of them so nobody gets anything and they go down too.. grow up you tools.. how about the ad rock scooper guy?? This whole board was filled with a bunch of tools telling people to scoop all those years.. they can suck my balls too

don't file a lawsuit - nah, don't do that. Never in my life have I come across a base of shareholders that were ALL f'n PANSIES like this group. WOW

Titan Medical has played us over and over with deception that they had a completed Robot looking to get final FDA approval. They lied several times to the share holders. They can’t get this bucket of shit to market because it didn’t get approval. This new company that’s willing to work with them are crazy , long shot to make anything. But it’s are only hope to get anything back. Sueing them won’t help us at all! We have all been bent over !

Bro, Really, post "Amalgamation Agreement value" ? They told you in a PR that your TMDI shares will be CONSOLIDATED. They told you this. In a press release. So it's gonna happen. Stop being such a homer and realize we have been robbed here. Yes, it's over for you, me and all TMDI shareholders. The new company sucks and that hybrid POS cardio device will never get traction in US. So again, get over it. Even if SP goes up, after consolidation you'll be fucked. Boom! Its over!

Ok but it's not over!
I mean that I don't sell the shares and I wait for them to rise at least up to the post Amalgamation Agreement value.
Amalgamation Agreement
It's a bit exotic
let's make an amalgam
I wonder why?
the sense of those who don't have shit to do? I don't know!

I don't blame any of us thinking this was gonna happen with Enos & MDT or any other RAS company. The patents are real and TMDI had them. We saw ENOS videos of a working robot. I thought for sure this would happen. I blindly ignored all the signs like many of us did.

Thanks for all the BOOM updates. But unfortunately it's over dude. Investors have been robbed here.

https://www.sedarplus.ca/csa-party/viewInstance/resource.html?node=W4757&drmKey=b9187c503568eeef&drr=ss4d574806812d6322686fc81087ab9fdef0c4f59efdc07eec29055e4f1331babe48ecc9dca354f74e4696a1c5fc60f380ux&id=0c11f8b7998bcd96c91e9e7d7a74b480832318a0e5b3d9de

I tried to write an email, I thought about it but we don't know anything!
We only know that someone estimated it at around 5 million or so I understand!
But we completely ignore what was evaluated!
Are we entitled to anything if and when Enos, or other patented technology, comes on the market?
Now this technology generates nothing, in fact we need to invest to see it on the market!
Could the new company have returns from this? Will everything be liquidated by the new management?
What are the prospects?
I only know that those who know have not sold!
It makes me vomit to think how much we have been fooled but we know nothing and perhaps we will never know anything!
So for now I don't know what to write to accuse them and I don't understand if it's worth it!
Market Cap $6.32M
Anyone who wants to get something back is probably better off voting YES to the RTO!
It makes me angry but I see a lawsuit as expensive and to get what then?
We can only speculate on the possibility that Vance acted in the sole interest of MDT.
I would like them to tell us something about the convenience of the RTO,
I wouldn't mind seeing something back!

Reverse Scoop us!!!!!!